Kaliumklorid Sad (Potassium Chloride)

Potassium chloride supplies potassium ions directly into the bloodstream. The increase in extracellular potassium raises serum levels, re‑establishing the normal electrochemical gradient across cell membranes. This stabilizes the resting membrane potential, improves neuromuscular function, and supports proper cardiac repolarization, thereby counteracting the physiological disturbances caused by low potassium.

The appropriate dose of Kaliumklorid Sad is determined by the prescribing clinician based on the patient’s current serum potassium, underlying condition, renal function, and rate of correction required. Dosage is individualized, and the product is administered under medical supervision in a controlled clinical environment.

Safety data for potassium chloride injection in pregnancy and lactation are limited, and the product should be used only if the potential benefit justifies any potential risk to the fetus or infant. Clinicians must evaluate maternal potassium status and consider alternative therapies when appropriate.

To request Kaliumklorid Sad, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling if needed—and assists with import documentation.

Compared with oral potassium salts, the intravenous formulation of Kaliumklorid Sad delivers potassium more rapidly and is suitable for patients who cannot tolerate oral intake or need immediate correction. It offers precise dosing and controlled infusion rates, whereas oral preparations have slower absorption and may cause gastrointestinal irritation.

Kaliumklorid Sad must be stored at 2‑8 °C in a refrigerator, protected from light, and should not be frozen or shaken. The vial should remain in its original packaging until use to maintain sterility and potency.

The solution is administered intravenously by a qualified healthcare professional. It is typically diluted in compatible IV fluids and infused over a period dictated by the prescribed dose and patient tolerance, with continuous monitoring of vital signs and serum potassium levels.

The most critical risks include severe hyperkalemia, which can precipitate life‑threatening cardiac arrhythmias or cardiac arrest, and anaphylactic reactions. Prompt recognition of symptoms such as chest pain, palpitations, or respiratory distress and immediate medical intervention are essential.

Kaliumklorid Sad is contraindicated in patients with known hypersensitivity to potassium chloride, those with severe hyperkalemia, or individuals with conditions that predispose to dangerous potassium accumulation, such as untreated adrenal insufficiency or uncontrolled renal failure, unless closely monitored by a specialist.